The problem of nonresponding estrogen receptor positive patients with advanced breast cancer.
Patients with advanced breast cancer and low or poor concentration of estrogen receptors in tumor biopsies have little chance of responding to endocrine therapy. This problem was seen in a group of nonresponding estrogen receptor positive (ER+) patients. Some comments on possible explanations for this phenomenon are made and suggestions to overcome it are given.